Cargando…
HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
Hepatitis B virus reactivation (HBV-R), which can lead to HBV-related morbidity and mortality, is a common and well-known complication that occurs during the treatment of non-Hodgkin lymphoma (NHL) patients with current or past exposure to HBV infection. HBV-R is thought to be closely associated wit...
Autores principales: | Cao, Xing, Wang, Yafei, Li, Panyun, Huang, Wei, Lu, Xiaojuan, Lu, Hongda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281013/ https://www.ncbi.nlm.nih.gov/pubmed/34277431 http://dx.doi.org/10.3389/fonc.2021.685706 |
Ejemplares similares
-
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma
por: Masarone, Mario, et al.
Publicado: (2014) -
Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
por: Ricci, Jean-Ehrland, et al.
Publicado: (2018) -
Editorial: HBV and lymphoma
por: Gentile, Giuseppe, et al.
Publicado: (2023) -
Cost-effectiveness of managing HBV reactivation in patients with resolved HBV infection treated with anti-CD20 antibody for B-cell non-Hodgkin lymphoma
por: Fujita, Misuzu, et al.
Publicado: (2022) -
Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma
por: Bodet-Milin, Caroline, et al.
Publicado: (2013)